Global Innovative Platforms (GIPL) Other Operating Expenses (2024 - 2026)
Global Innovative Platforms' (GIPL) quarterly Other Operating Expenses came in at -$1.0 in Q1 2026, up 100.0% year-over-year from -$0.5 in Q1 2025, and down 100.0% quarter-over-quarter from $20733.0 in Q3 2025.
Powered by 
Analysis
Global Innovative Platforms (GIPL) Other Operating Expenses (2024 - 2026) Analysis & Trends
Global Innovative Platforms has disclosed Other Operating Expenses across 3 years of filings, most recently posting -$1.0 for Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Idexx Laboratories | 42.23 Bn | 42.03 Bn | 779.09 Mn |
| 2 | Zoetis | 31.39 Bn | 29.72 Bn | 1.05 Bn |
| 3 | Elanco Animal Health | 12.21 Bn | 11.68 Bn | 798.00 Mn |
| 4 | Phibro Animal Health | 1.55 Bn | 1.47 Bn | 134.40 Mn |
| 5 | Immucell | 89.91 Mn | 81.05 Mn | 2.44 Mn |
| 6 | Zhengye Biotechnology Holding | 76.30 Mn | 77.22 Mn | - |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -1.00 |
| Sep 30, 2025 | 20,733.00 |
| Jun 30, 2025 | -211,818.00 |
| Mar 31, 2025 | -151,351.00 |
| Sep 30, 2024 | 23,376.00 |